CN1456227A - Medicine for curing hepatitis B - Google Patents
Medicine for curing hepatitis B Download PDFInfo
- Publication number
- CN1456227A CN1456227A CN03118601A CN03118601A CN1456227A CN 1456227 A CN1456227 A CN 1456227A CN 03118601 A CN03118601 A CN 03118601A CN 03118601 A CN03118601 A CN 03118601A CN 1456227 A CN1456227 A CN 1456227A
- Authority
- CN
- China
- Prior art keywords
- radix
- herba
- medicine
- hepatitis
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
A Chinese medicine for treating hepatitis B is prepared from 17 Chinese-medicinal materials including oriental wormwood, red peony root, red sage root, Chinese angelica root, etc. Its advantages are high curative effect, quickly taking its effect, short course of treatment, low cost and no toxic by-effect.
Description
(1) technical field:
The present invention relates to a kind of medicine for the treatment of hepatitis B, is the Chinese medicine preparation of treatment hepatitis B specifically.
(2) technical background:
Hepatitis B is the higher infectious disease of a kind of sickness rate, especially in China, hepatitis B patient and virus carrier are up to people more than 100,000,000, account for 10% of country's total population, in some high region of disease, hepatitis B patient reaches more than 70% unexpectedly, present stage is the traditional Chinese medical science or doctor trained in Western medicine no matter, treatment to hepatitis B does not all have specially good effect, especially in the rural area, owing to reasons such as treatment instability, treatment phase length, expense height, cause some hepatitis B patients to develop into liver cirrhosis even hepatocarcinoma, all cause very big injury for patient and family.
(3) summary of the invention:
The object of the present invention is to provide a kind of Chinese medicine preparation of effective treatment hepatitis B, through clinical confirmation, medicine of the present invention has effects such as obviously killing hepatitis B virus, promotion liver cell regeneration, enhancing liver immunity.
Make (by weight) by following raw material during medicine of the present invention:
Herba Sedi 7-10 Herba Artemisiae Scopariae 7-10
Herba Portulacae 7-10 Radix Paeoniae Rubra 5.5-7.5
Radix Salviae Miltiorrhizae 5.5-7.5 Rhizoma Polygoni Cuspidati 5.5-7.5
Herba Hedyotidis Diffusae 5.5-7.5 Radix Angelicae Sinensis 5.5-7.5
Fructus Schisandrae Chinensis 5.5-7.5 Poria 5.5-7.5
Radix Sophorae Flavescentis 5.5-7.5 Radix Curcumae 5.5-7.5
Radix Astragali 5.5-7.5 Herba Siphonostegiae 5.5-7.5
Fructus Hordei Germinatus 5.5-7.5 Endothelium corneum 5.5-7.5
Massa Medicata Fermentata (parched to brown) 5.5-7.5
Above-mentioned each component preferred weight proportioning is:
Herba Sedi 8 Herba Artemisiae Scopariaes 8
Herba Portulacae 8 Radix Paeoniae Rubra 6
Radix Salviae Miltiorrhizae 6 Rhizoma Polygoni Cuspidati 6
Herba Hedyotidis Diffusae 6 Radix Angelicae Sinensis 6
Fructus Schisandrae Chinensis 6 Poria 6
Radix Sophorae Flavescentis 6 Radix Curcumaes 6
The Radix Astragali 6 Herba Siphonostegiae 6
Fructus Hordei Germinatus 6 Endothelium corneum 6
Massa Medicata Fermentata (parched to brown) 6
The preparation method of medicine of the present invention is:
With the selected raw material of said medicine, be ground into fine powder after the oven dry, after the sieve mixing, per 100 grams add 20-40 gram refined honey and low amounts of water, make water-honeyed pill, dry again getting final product.
Perhaps,, be ground into fine powder after the oven dry, further pulverize behind the mix homogeneously, cross 100 mesh sieves, incapsulate and to get the selected raw material of said medicine.
The clinical use result of medicine 1995-2001 of the present invention shows, has the following advantages:
1, our medicine source is extensive, easily adopts to be easy to get, and is with low cost;
2, we adopt natural drug, and nontoxic to human body, drug safety is reliable;
3, production technology is simple, taking convenience, and short treating period, instant effect, and evident in efficacy.
For showing the therapeutic effect of medicine of the present invention to hepatitis B, the present invention is through clinical observation, and data is as follows:
1, case choice criteria:
Traditional medicine thinks that the hepatitis B pathogenesis is: damp and hot surplus heresy is not most, stagnation of liver-QI with deficiency of the spleen, and QI and blood deficiency is so the differential diagnosis in tcm standard is: refreshing tired power, the soreness of waist, dizziness, tinnitus, dim eyesight, red tongue, thready and stringy pulse.
2, diagnostic criteria:
" viral hepatitis is prevented and treated scheme " of Shanghai meeting revision is diagnostic criteria with nineteen ninety, and hepatitis history surpasses half a year, and more than one positive signs that have present situation HBV to infect.
3, curative effect judging standard:
Related content with 1993 " traditional Chinese medical science Clinical Researches of New Drugs guideline " first volume is a curative effect judging standard.Produce effects: symptom, sign disappear, and liver function is normal, and the hbv replication index all disappears; Effectively: symptom and liver function are all improved or the hbv replication index has more than one and turns out cloudy; Invalid: symptom, sign do not change, and liver function is not improved.
4, physical data:
Select case 500 examples altogether by standard: 500 examples are organized in treatment, and great three positive has 225 examples, and small three positive has 190 examples, HBsAg carrier 85 examples, male's 382 examples wherein, women's 118 examples, 40.5 years old mean age, average course of disease 2.8 years; Matched group 100 examples, great three positive has 51 examples, and small three positive has 38 examples, HBsAg carrier 11 examples, male's 72 examples wherein, women's 28 examples, 39.6 years old mean age, average course of disease 2.6 years.
Administrated method and consumption: the treatment group is taken medicine of the present invention, and is oral, every day 3 times, and one time 5 gram, 3 months is a course of treatment; Matched group is taken " hepatitis B recuperating medicine capsule ", and is oral, every day 3 times, and one time 12 gram, 3 months is a course of treatment.
Result such as following table:
The treatment group hepatitis B patient situation observation table table 1 of turning out cloudy:
| Type | Before the treatment | After the treatment | |||||||||||
| The case sum | HBsAg | Anti-HBs | ?HBeAg | Anti-HBe | Anti-HBc | The number of turning out cloudy | Do not change number | HBsAg | Anti-HBs | ?HBeAg | Anti-HBe | Anti-HBc | |
| Great three positive | ??225 | ???+ | ??- | ????+ | ??- | ???+ | ??216 | ???- | ??+ | ????- | ??- | ??- | |
| ??9 | ???+ | ??- | ????+ | ??- | ??- | ||||||||
| Small three positive | ??190 | ??+ | ???- | ???- | ???+ | ???+ | ??182 | ???- | ???+ | ???- | ??- | ??- | |
| ??8 | ???+ | ???- | ???- | ??+ | ??+ | ||||||||
| Carrier | ??85 | ??+ | ??- | ???- | ??- | ??- | ??82 | ???- | ???+ | ???- | ??- | ??- | |
| ??3 | ???+ | ??- | ???- | ??- | ??- | ||||||||
| Add up to | ??500 | ??480 | ??20 | ||||||||||
Treatment group and matched group effective percentage comparison sheet table 2:
| Group | Example number (%) | Produce effects (%) | Effectively (%) | Invalid (%) | Total effective rate (%) |
| The treatment group | ????500 | ?288(57.6) | ????192(38.4) | ????20(4) | ????96 |
| Matched group | ????100 | ?32(32) | ????30(30) | ????38(38) | ????62 |
Result of study shows: take medicine of the present invention, obvious effective rate is 57.6%, and effective percentage is 38.4%, and total effective rate is 96%, obviously is better than matched group at aspects such as killing hepatitis B virus, promotion liver cell regeneration, enhancing liver immunity.
(4), embodiment:
Get raw material (gram) by following proportioning
Herba Sedi 8 Herba Artemisiae Scopariaes 8
Herba Portulacae 8 Radix Paeoniae Rubra 6
Radix Salviae Miltiorrhizae 6 Rhizoma Polygoni Cuspidati 6
Herba Hedyotidis Diffusae 6 Radix Angelicae Sinensis 6
Fructus Schisandrae Chinensis 6 Poria 6
Radix Sophorae Flavescentis 6 Radix Curcumaes 6
The Radix Astragali 6 Herba Siphonostegiae 6
Fructus Hordei Germinatus 6 Endothelium corneum 6
Massa Medicata Fermentata (parched to brown) 6
Preparation method is as follows:
With the selected raw material of said medicine, be ground into fine powder after the oven dry, after the sieve mixing, per 100 grams add 20-40 gram refined honey and low amounts of water, make water-honeyed pill, dry again getting final product.
Perhaps,, be ground into fine powder after the oven dry, further pulverize behind the mix homogeneously, cross 100 mesh sieves, incapsulate and to get the selected raw material of said medicine.
Claims (3)
1, a kind of medicine for the treatment of hepatitis B is characterized in that it is the medicament of being made by the following weight proportion raw material:
Herba Sedi 7-10 Herba Artemisiae Scopariae 7-10
Herba Portulacae 7-10 Radix Paeoniae Rubra 5.5-7.5
Radix Salviae Miltiorrhizae 5.5-7.5 Rhizoma Polygoni Cuspidati 5.5-7.5
Herba Hedyotidis Diffusae 5.5-7.5 Radix Angelicae Sinensis 5.5-7.5
Fructus Schisandrae Chinensis 5.5-7.5 Poria 5.5-7.5
Radix Sophorae Flavescentis 5.5-7.5 Radix Curcumae 5.5-7.5
Radix Astragali 5.5-7.5 Herba Siphonostegiae 5.5-7.5
Fructus Hordei Germinatus 5.5-7.5 Endothelium corneum 5.5-7.5
Massa Medicata Fermentata (parched to brown) 5.5-7.5
2, the medicine of treatment hepatitis B as claimed in claim 1, wherein the weight proportion of each raw material is:
Herba Sedi 8 Herba Artemisiae Scopariaes 8
Herba Portulacae 8 Radix Paeoniae Rubra 6
Radix Salviae Miltiorrhizae 6 Rhizoma Polygoni Cuspidati 6
Herba Hedyotidis Diffusae 6 Radix Angelicae Sinensis 6
Fructus Schisandrae Chinensis 6 Poria 6
Radix Sophorae Flavescentis 6 Radix Curcumaes 6
The Radix Astragali 6 Herba Siphonostegiae 6
Fructus Hordei Germinatus 6 Endothelium corneum 6
Massa Medicata Fermentata (parched to brown) 6
3,, it is characterized in that said medicament is a said dosage form on any pharmaceutics as the medicine of claim 1,2 described treatment hepatitis ies.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031186017A CN1190229C (en) | 2003-02-12 | 2003-02-12 | Medicine for curing hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031186017A CN1190229C (en) | 2003-02-12 | 2003-02-12 | Medicine for curing hepatitis B |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1456227A true CN1456227A (en) | 2003-11-19 |
| CN1190229C CN1190229C (en) | 2005-02-23 |
Family
ID=29411326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031186017A Expired - Fee Related CN1190229C (en) | 2003-02-12 | 2003-02-12 | Medicine for curing hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1190229C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100460010C (en) * | 2005-05-29 | 2009-02-11 | 王福山 | Chinese medicine composition for treating hepatitis B and viral hepatitis |
| CN105412645A (en) * | 2015-12-04 | 2016-03-23 | 青岛安倍康生物医药技术有限公司 | Herba portulacae oral liquid for clearing heat and promoting diuresis, expelling toxin and protecting liver and preparation method of oral liquid |
| CN107343948A (en) * | 2017-08-04 | 2017-11-14 | 成都市飞龙水处理技术研究所 | It is a kind of effectively to treat pill medicine of hepatitis B and preparation method thereof |
-
2003
- 2003-02-12 CN CNB031186017A patent/CN1190229C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100460010C (en) * | 2005-05-29 | 2009-02-11 | 王福山 | Chinese medicine composition for treating hepatitis B and viral hepatitis |
| CN105412645A (en) * | 2015-12-04 | 2016-03-23 | 青岛安倍康生物医药技术有限公司 | Herba portulacae oral liquid for clearing heat and promoting diuresis, expelling toxin and protecting liver and preparation method of oral liquid |
| CN107343948A (en) * | 2017-08-04 | 2017-11-14 | 成都市飞龙水处理技术研究所 | It is a kind of effectively to treat pill medicine of hepatitis B and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1190229C (en) | 2005-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1150922C (en) | Medicated wine for treating rheumatism, rheumatoid disease and other arthralgia | |
| CN1692939A (en) | Traditional Chinese medicine pill for treating hepatitis B, and its prepn. method | |
| CN1839944A (en) | Granular composition for reducing blood fat and process for producing the same | |
| CN1686502A (en) | Medicine for fortifying human body immune function | |
| CN1137696C (en) | Medicine for treating hepatitis B and rheumatoid diseases | |
| CN1190229C (en) | Medicine for curing hepatitis B | |
| CN100340286C (en) | Medicine for treating hepatitis B and its preparing method | |
| CN1066628C (en) | Medicine for chronic hepatitis B and its preparation | |
| CN1051471C (en) | Drug composition for curing osteoporosis | |
| CN1319587C (en) | Medicine powder for liver and spleen diseases | |
| CN1059104C (en) | Capsule for anti hepatitis B | |
| CN1302799C (en) | Oral Chinese medicinal composition for treating virus myocarditis | |
| CN1074292C (en) | Cancer treating medicine capsule | |
| CN1292766C (en) | Chinese medicinal preparation for treating viral myocarditis and its making method | |
| CN1169555C (en) | Decocted pill medicine for treating excess syndrome of hepatitis B | |
| CN1136939A (en) | Chinese drugs for curing hepatitis B | |
| CN1195541C (en) | Medicine combination for treating chronic hepatitis B | |
| CN1047944C (en) | Capsule for curing hepatitis | |
| CN1042597C (en) | Vision-brighting and blood sugar decreasing composition and its produciton | |
| CN1310669C (en) | Medicine composition for treating chronic hepatitis and its prepn | |
| CN1159057C (en) | Medicine for treating hepatitis, and preparing process thereof | |
| CN1352966A (en) | Medicine for treating tracheitis and asthma | |
| CN1086949C (en) | Chinese medicine for hepatitis B and its preparation | |
| CN1660282A (en) | Combination of medication for treating hepatitis B and preparation method | |
| CN1340353A (en) | Orally-applied medicine for treating hepatism and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |